CA2225282A1 - 1,6-disubstituted isochromans for treatment of migraine headaches - Google Patents
1,6-disubstituted isochromans for treatment of migraine headaches Download PDFInfo
- Publication number
- CA2225282A1 CA2225282A1 CA002225282A CA2225282A CA2225282A1 CA 2225282 A1 CA2225282 A1 CA 2225282A1 CA 002225282 A CA002225282 A CA 002225282A CA 2225282 A CA2225282 A CA 2225282A CA 2225282 A1 CA2225282 A1 CA 2225282A1
- Authority
- CA
- Canada
- Prior art keywords
- ethyl
- defined above
- isochroman
- alkyl
- piperazinyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/76—Benzo[c]pyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74195P | 1995-06-30 | 1995-06-30 | |
| US60/000,741 | 1995-06-30 | ||
| US1123496P | 1996-02-06 | 1996-02-06 | |
| US60/011,234 | 1996-02-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2225282A1 true CA2225282A1 (en) | 1997-01-23 |
Family
ID=26668092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002225282A Abandoned CA2225282A1 (en) | 1995-06-30 | 1996-06-07 | 1,6-disubstituted isochromans for treatment of migraine headaches |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0836599A1 (pt) |
| JP (1) | JPH11509532A (pt) |
| AU (1) | AU6252296A (pt) |
| BR (1) | BR9609631A (pt) |
| CA (1) | CA2225282A1 (pt) |
| CZ (1) | CZ418597A3 (pt) |
| FI (1) | FI974640A (pt) |
| MX (1) | MX9710260A (pt) |
| NO (1) | NO976112L (pt) |
| PL (1) | PL324319A1 (pt) |
| SK (1) | SK164297A3 (pt) |
| WO (1) | WO1997002259A1 (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2370270A (en) * | 2000-12-20 | 2002-06-26 | Lilly Co Eli | Pharmaceutical compounds |
| US7335660B2 (en) | 2001-12-19 | 2008-02-26 | Eli Lilly And Company | Isochroman compounds for treatment of CNS disorders |
| GB0130339D0 (en) * | 2001-12-19 | 2002-02-06 | Lilly Co Eli | Isochroman compounds |
| US7110576B2 (en) | 2002-12-30 | 2006-09-19 | Pitney Bowes Inc. | System and method for authenticating a mailpiece sender |
| ES2338668T3 (es) | 2004-05-05 | 2010-05-11 | F. Hoffmann-La Roche Ag | Arilsulfonil benzodioxanos utiles para la modulacion del receptor 5-ht6 y del receptor 5-ht2a o ambos. |
| DK1831159T3 (da) | 2004-12-21 | 2010-03-22 | Hoffmann La Roche | Tetralin og indanderivater samt anvendelser deraf |
| RU2388748C2 (ru) | 2004-12-21 | 2010-05-10 | Ф. Хоффманн-Ля Рош Аг | Производные тетралина и индана и их применения в качестве антагонистов 5-нт |
| WO2006066756A1 (en) | 2004-12-21 | 2006-06-29 | F. Hoffmann-La Roche Ag | Chroman derivatives and uses thereof in the treatment of cns disorders |
| AU2005318596B2 (en) | 2004-12-21 | 2010-12-23 | F. Hoffmann-La Roche Ag | Chroman derivatives and their use as 5-HT receptor ligands |
| KR100899061B1 (ko) | 2004-12-21 | 2009-05-25 | 에프. 호프만-라 로슈 아게 | 테트랄린 및 인단 유도체 및 이의 용도 |
| CN101300246A (zh) | 2005-11-03 | 2008-11-05 | 弗·哈夫曼-拉罗切有限公司 | 作为5－ht6抑制剂的芳基磺酰基色满类化合物作为蛋白激酶抑制剂的吲哚基马来酰亚胺衍生物 |
| BRPI0713736A2 (pt) | 2006-06-20 | 2014-11-18 | Hoffmann La Roche | Derivados de tetralina e indano e emprego destes |
| BRPI0713742A2 (pt) | 2006-06-20 | 2013-02-13 | Hoffmann La Roche | derivados de arilsulfonila naftaleno e usos destes |
| KR101064001B1 (ko) | 2006-06-20 | 2011-09-08 | 에프. 호프만-라 로슈 아게 | 아릴설폰아미딜 테트랄린 유도체 및 이의 용도 |
| EP2404897A4 (en) * | 2009-03-05 | 2014-02-26 | Sumitomo Chemical Co | PROCESS FOR PREPARING HALOGEN-SUBSTITUTED BENCHENETIMETHANOL |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1552004A (en) * | 1976-05-26 | 1979-09-05 | Takeda Chemical Industries Ltd | Isochroman derivatives |
| DK0737189T3 (da) * | 1993-12-28 | 2000-03-06 | Upjohn Co | Heterocycliske forbindelser til behandling af CNS-forstyrrelser og cardiovaskulære forstyrrelser |
-
1996
- 1996-06-07 PL PL96324319A patent/PL324319A1/xx unknown
- 1996-06-07 CA CA002225282A patent/CA2225282A1/en not_active Abandoned
- 1996-06-07 BR BR9609631A patent/BR9609631A/pt not_active Application Discontinuation
- 1996-06-07 JP JP9505135A patent/JPH11509532A/ja active Pending
- 1996-06-07 MX MX9710260A patent/MX9710260A/es unknown
- 1996-06-07 SK SK1642-97A patent/SK164297A3/sk unknown
- 1996-06-07 CZ CZ974185A patent/CZ418597A3/cs unknown
- 1996-06-07 EP EP96921264A patent/EP0836599A1/en not_active Withdrawn
- 1996-06-07 AU AU62522/96A patent/AU6252296A/en not_active Abandoned
- 1996-06-07 WO PCT/US1996/008681 patent/WO1997002259A1/en not_active Application Discontinuation
-
1997
- 1997-12-29 NO NO976112A patent/NO976112L/no unknown
- 1997-12-30 FI FI974640A patent/FI974640A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX9710260A (es) | 1998-03-29 |
| SK164297A3 (en) | 1998-09-09 |
| FI974640A0 (fi) | 1997-12-30 |
| BR9609631A (pt) | 1999-03-02 |
| JPH11509532A (ja) | 1999-08-24 |
| NO976112D0 (no) | 1997-12-29 |
| PL324319A1 (en) | 1998-05-25 |
| FI974640A (fi) | 1997-12-30 |
| NO976112L (no) | 1998-03-02 |
| EP0836599A1 (en) | 1998-04-22 |
| CZ418597A3 (cs) | 1998-06-17 |
| WO1997002259A1 (en) | 1997-01-23 |
| AU6252296A (en) | 1997-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2225282A1 (en) | 1,6-disubstituted isochromans for treatment of migraine headaches | |
| KR102473481B1 (ko) | 강력하고 선택적인 rock 억제제로서의 락탐, 시클릭 우레아 및 카르바메이트, 및 트리아졸론 유도체 | |
| US6965036B2 (en) | Intermediates for guanidine mimics as factor Xa inhibitors | |
| EP0359418B1 (en) | 5'-Indolinyl-5beta-amidomethyloxazolidin-2-ones, 3-(fused-ring substituted)phenyl-5beta-amidomethyloxazolidin-2-ones and 3-(nitrogen substituted)phenyl-5beta-amidomethyloxazolidin-2-ones | |
| RU2159238C2 (ru) | Бензофураны и способ их получения | |
| USRE41425E1 (en) | Piperazine and piperidine compounds | |
| AU631990B2 (en) | New aminopiperidine, aminopyrrolidine and aminoperhydroazepine compounds, processes for their preparation thereof and pharmaceutical compositions containing them | |
| CA2716369C (en) | Phenoxypropylamine compounds | |
| CA2617654A1 (en) | Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds | |
| WO1996018628A1 (en) | Alkyl substituted piperadinyl and piperazinyl anti-aids compounds | |
| WO2007042660A2 (fr) | Dérivés de la 1-amino-phtalazine substituee, leur préparation et leur application en thérapeutique | |
| ES2291913T3 (es) | Piperidinas sustituidas como ligandos del receptor h3 de la histamina. | |
| FI96949C (fi) | Menetelmä pikornaviruksia vastaan vaikuttavien pyridatsiiniamiinien valmistamiseksi ja menetelmässä käyttökelpoiset välituotteet | |
| BRPI0709101A2 (pt) | derivados de triazolona e medicamento e agente terapêutico e/ou profilático compreendendo os mesmos | |
| CZ283993A3 (en) | Phenoxy- and phenoxyalkyl piperidines as antiviral active substances | |
| AU645707B2 (en) | Piperidine derivatives | |
| CA2332513C (fr) | Nouveaux derives de 4-sulfonamides piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| AU746721B2 (en) | Chemical synthesis of morpholine derivatives | |
| HU204274B (en) | Process for producing 4-substituted pyrazolo(3,4-d)pyrimidine derivatives and pharmaceutical compositions containing them as active components | |
| KR101522125B1 (ko) | Nk3 길항제로서의 피롤리딘 유도체 | |
| WO1999032446A1 (fr) | Agent de conservation de fraicheur pour fleurs coupees | |
| US7777048B2 (en) | Processes for preparing biaryl ureas and analogs thereof | |
| NO148747B (no) | Analogifremgangsmaate til fremstilling av n-fenyl-n-(4-piperidinyl)lavere alkyl-tetrazolamider | |
| RU2798336C2 (ru) | Новые соединения для лечения инфекций млекопитающих | |
| KR100365082B1 (ko) | 불안증및수면장애치료용이미다조[1,5-a]퀴놀린 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |